Items Tagged ‘Food and Drug Administration’
September 26, 2013
Mayo Clinic in the News Weekly Highlights
September 27, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]
Tags: ABC News, ABCnews.com, Affordable care act, Arizona State University, ASU Insight, Batman, blood biomarker, Bob Nellis, Breast Cancer, CDC, Chris Gade, CNBC
February 22, 2013
Mayo Clinic in the News Weekly Highlights
February 22, 2013 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media […]
Tags: American Gastroenterological Association, Barrett's esophagus, Cannon Falls, Cannon Falls Beacon, cardiovascular surgery, chronic acid reflux, Controlled Substances Act, Decade of Discovery, destination medical center, DMC, Dr. Bradly Narr, Dr. C. Daniel Smith
July 10, 2012
FDA Panel Supports Continued Testing of Pain Drugs
A panel of arthritis experts recommended Monday that the federal government allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure. The Food and Drug Administration’s 21-member panel of arthritis experts voted unanimously that research on the nerve-blocking drugs should continue, with certain safety precautions. […]
June 15, 2012
Mayo Clinic in the News Weekly Highlights
June 15, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations NY […]
Tags: Chicago Tribune, Dr. Chet Rihal, Dr. David Hayes, Dr. Dennis Dickson, Dr. John Armstrong, Dr. Sharonne Hayes, Fairview Red Wing Health Services, Food and Drug Administration, Good Morning Arizona, Jacksonville Business Journal, Lawrence Matteson, Marylin Matteson
June 11, 2012
New Drug Can Fight Inherited Skin Cancer
There is a new drug to fight skin cancer for the sun-splashed masses of Arizona. The drug, vismodegib, was approved by the Food and Drug Administration in January for people with an advanced form of one type of skin cancer, basal-cell carcinoma. New research unveiled last week by local doctors and other scientists shows that […]
Tags: Aleksander Sekulic, Arizona Republic, carcinoma, Food and Drug Administration, New England Journal of Medicine, skin cancer
April 17, 2012
Another Amyloid Tracer Shows Promise in Alzheimer’s
On the heels of the US Food and Drug Administration (FDA) approval of the amyloid tracer agent florbetapir (Amyvid, Eli Lilly), another biomarker is showing promise in detecting beta-amyloid deposition in the brains of living patients…Asked for his opinion, David Knopman, MD, Department of Neurology, Mayo Clinic, Rochester, Minnesota, said he found the accuracy of […]
Tags: Dr. David Knopman, florbetapir, Food and Drug Administration
February 23, 2012
FDA to review safety of caffeine product
Food and Drug Administration officials plan to investigate whether a form of caffeine sold in lipstick-shaped containers is safe for consumers. The inventor touts AeroShot as caffeine without the coffee, soda, tea or a pill, but a U.S. lawmaker questions whether it’s safe…”For most healthy adults, moderate doses of caffeine — 200mg to 300mg, or […]
Tags: AeroShot, Food and Drug Administration, lipstick-shaped containers of caffeine
February 9, 2012
FDA panel votes against Xgeva for prostate cancer
panel of cancer experts voted against a new use for Amgen’s Xgeva in prostate cancer on Wednesday, saying the drug’s ability to slow the spread of the disease did not translate into meaningful benefits for patients.The Food and Drug Administration’s cancer drug panel voted 12-1 that the benefits of the drug did not outweigh its […]
Tags: amgen, cancer drug panel, Dr. Ronald Richardson, FDA, Food and Drug Administration, prostate cancer, Xgeva